2030 participants
A Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-11-21
- Start Date:
- 2009-04-28
- Completion:
- 2010-04-27
Conditions
- Urinary Bladder, Overactive
Interventions
- DRUG